thomasmorgan
November 13th, 2009
Genetic Testing in Unexplained Thrombosis – Part II
thomasmorgan and Richard A. Lange, MD, MBA
An expert weighs in on a case of unexplained VTE in a patient under 50. (see Part I) The rationale for genetic testing in unexplained thrombosis is to gain a better understanding of why VTE occurred and to document risk factors for recurrent events. However, genetic testing in this setting is somewhat controversial. Knowing […]
NEJM Journal Watch — Recent Cardiology Articles- To Lower Stroke Risk in Patients Undergoing Atrial Fibrillation Ablation, Is a Device or a Medication Better?
- Intensive vs. Standard Blood Pressure Lowering in Patients with Diabetes
- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy